Florida vs Pennsylvania
Side-by-side analysis of Florida and Pennsylvania for cannabis business strategy, with a decisive recommendation from Hoban Law Group.
Side-by-Side Comparison
| Factor | Florida | Pennsylvania | Verdict |
|---|---|---|---|
| Adult-use status | Medical only — Amendment 3 pending implementation | Medical only — adult-use ballot effort in progress | Neutral Both states are currently medical-only. Florida's Amendment 3 passed in 2024 but adult-use implementation is pending enabling legislation. |
| Medical market size | $2B+ medical program — largest medical-only market | ~$1.8B medical program — strong Mid-Atlantic patient base | Florida wins Florida is the largest medical-only cannabis market in the US by revenue, driven by its large senior population and favorable medical conditions list. |
| License structure | MMTC — vertically integrated license required | Grower/Processor/Dispensary — separate or vertically integrated | Pennsylvania wins Florida requires operators to hold a single vertically integrated MMTC license covering cultivation, processing, and retail — a capital-intensive entry point with no segmentation option. |
| License cost and scarcity | MMTC licenses: $5-30M+ on secondary market | Grower/Processor licenses: $1-5M+ on secondary market | Pennsylvania wins Florida MMTC licenses are among the most expensive cannabis licenses in the US due to their forced vertical integration and limited total count. |
| Adult-use transition risk | High — enabling legislation contested | Moderate — ballot initiative pathway underway | Neutral Both states face political uncertainty around adult-use transition; Florida's Amendment 3 has a clearer legal mandate but faces legislative resistance. |
| Regulatory body | Office of Medical Marijuana Use (OMMU) | Pennsylvania Department of Health | Pennsylvania wins Pennsylvania's DOH has run a more transparent and consistently administered medical program than Florida's OMMU, which has faced criticism for inconsistent enforcement and slow guidance. |
Florida vs Pennsylvania: Medical Cannabis Market Comparison
Florida and Pennsylvania are two of the largest medical cannabis markets in the United States, and both are positioned as potential major adult-use markets as legalization continues to expand. Understanding their current structures is essential for operators considering positioning ahead of adult-use transitions.
Florida: The Largest Medical Market
Florida operates one of the most distinctive cannabis licensing structures in the United States. Medical Marijuana Treatment Center (MMTC) licenses require full vertical integration — licensees must cultivate, process, and dispense their own cannabis. There is no option to be a standalone cultivator, processor, or dispensary; the license bundles all three tiers.
This structure dramatically raises the capital requirement for Florida entry. MMTC licenses on the secondary market have traded at $5-30M+ depending on the operator's existing dispensary footprint and cultivation infrastructure. Florida's total MMTC count has expanded but remains limited, preserving significant secondary market value.
Florida's medical program serves over 800,000 active patients, making it the largest medical-only cannabis program in the US by patient count and revenue. The state's large senior population and favorable qualifying conditions list have driven strong patient growth.
Adult-Use Transition: Amendment 3
Florida voters passed Amendment 3 in November 2024, legalizing adult-use cannabis. However, implementation requires enabling legislation from the Florida Legislature, which has been contested. The timeline and structure of adult-use licensing remain uncertain, creating significant opportunity risk for operators positioning for the adult-use transition.
Pennsylvania: The Mid-Atlantic Medical Market
Pennsylvania's medical cannabis program allows separate grower/processor and dispensary licenses, giving operators more flexibility to participate in specific supply chain segments without mandatory full vertical integration. Pennsylvania's DOH-administered program has been generally consistent and transparent.
Pennsylvania is actively pursuing adult-use legalization via ballot initiative, though a legislative path has not materialized. The state's proximity to New York, New Jersey, and Maryland creates a competitive adult-use landscape that will eventually affect patient retention.
Decision framework
Which fits your business?
Which market fits your business? Florida is the right choice for operators with significant capital who want exposure to the largest medical cannabis market in the US and want to position ahead of what could be the most valuable adult-use market transition in American cannabis history — if enabling legislation passes. The capital requirement is high, and the adult-use timeline is uncertain, but the asymmetric upside is real. Pennsylvania is the better choice for operators with less capital who want flexibility to enter a specific supply chain tier, prefer a more administratively consistent regulatory environment, and are willing to participate in a smaller but well-organized Mid-Atlantic market. Hoban Law Group has advised clients in both states on medical licensing, M&A, and adult-use transition strategy. [Schedule a consultation](/consultation?source=compare&compare=florida-vs-pennsylvania&matter_type=licensing).
Frequently Asked Questions
- What is an MMTC license in Florida and how is it different from licenses in other states?
- A Medical Marijuana Treatment Center license in Florida requires the licensee to vertically integrate all cannabis operations — cultivation, processing, testing, and retail dispensing — under a single license. This is unusual in the US cannabis industry, where most states allow operators to hold licenses in specific tiers of the supply chain.
- When will Florida launch adult-use cannabis following Amendment 3?
- Amendment 3 passed in November 2024, but adult-use implementation requires enabling legislation from the Florida Legislature. As of 2026, the legislative timeline remains contested. Conservative estimates suggest adult-use sales could begin by 2026-2027 if enabling legislation passes.
- Is Pennsylvania likely to legalize adult-use cannabis?
- Pennsylvania has been pursuing adult-use legalization through a combination of legislative and ballot initiative efforts. Neighboring states Maryland, New Jersey, and New York are all adult-use, creating significant cross-border commerce pressure that has accelerated Pennsylvania's adult-use advocacy.
- What are the key differences between Florida and Pennsylvania cannabis regulations?
- The most significant difference is Florida's forced vertical integration requirement (MMTC model) vs Pennsylvania's tiered licensing that allows operators to participate in specific supply chain segments. Florida has higher entry costs but a significantly larger patient base.
Work with Hoban Law Group
Get counsel on your Florida or Pennsylvania matter
Our team prepares a regulatory briefing specific to your matter before you speak with counsel. No cost. No commitment.
Schedule a consultation